AstraZeneca’s rare disease drug Fasenra gets US regulator’s nod
The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.
Antibiotic-resistant infections may kill 39.1 million people in the next 25 years equating to three deaths a minute, a global study finds.
Daiichi Sankyo and Merck & Co., Inc. will initiate talks with global regulatory agencies after an end-stage trial of its drug for a.
HQ Team September 14, 2024: High doses of Attention Deficit and Hyperactivity Disorder (ADHD) medicines can lead to a greater risk of developing.
HQ Team September 13, 2024: More than 22,500 people, a quarter of those wounded in Gaza since Israel’s offensive began in October ’23,.
HQ Team September 13, 2024: The U.S. Food and Drug Administration (FDA) has issued a safety warning about Veozah (fezolinetant), a medication prescribed.
Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat.
The phrase "It takes a village to raise a child" emphasizes the importance of children interacting with diverse individuals beyond their immediate family..
Six staff members working for the United Nations Relief and Works Agency for Palestinian refugees were killed in Gaza during Israeli airstrikes on.
Merck & Co., announced it has met its primary and secondary goals during the end-stage trials of its human papillomavirus (HPV) vaccine in.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com